JAZZ
Jazz Pharmaceuticals plc · Healthcare · Biotechnology
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 135 | +4 | 47.42M | $11.41B | +7 | −4 |
| Q1 2026 | 135 | -10 | 49.63M | $8.67B | +4 | −14 |
| Q4 2025 | 144 | +2 | 48.56M | $7.62B | +2 | n/a |
| Q3 2025 | 20 | 0 | 25.68M | $3.38B | +1 | −1 |
| Q2 2025 | 17 | -1 | 21.49M | $2.28B | +1 | −2 |
| Q1 2025 | 15 | 0 | 8.34M | $1.04B | +1 | −1 |
| Q4 2024 | 15 | 0 | 8.56M | $1.05B | +1 | −1 |
| Q3 2024 | 14 | -2 | 7.38M | $822.21M | n/a | −2 |
| Q2 2024 | 16 | n/a | 7.74M | $826.28M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 2.02M | n/a | $215.55M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Baupost Group ✦ | 1.27M | n/a | $136.00M | 3.9% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 1.11M | n/a | $119.02M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Renaissance Technologies ✦ | 1.03M | n/a | $109.49M | 0.2% | n/c | 1 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 619.10K | n/a | $66.08M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 6 | Millennium Management ✦ | 450.87K | n/a | $48.12M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Citadel Advisors ✦ | 388.70K | n/a | $41.49M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | D. E. Shaw & Co. ✦ | 255.87K | n/a | $27.31M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Point72 Asset Management ✦ | 182.01K | n/a | $19.43M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Bridgewater Associates ✦ | 101.14K | n/a | $10.79M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 93.40K | n/a | $9.97M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Marshall Wace ✦ | 82.96K | n/a | $8.85M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 48.57K | n/a | $5.18M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 14 | Arrowstreet Capital ✦ | 44.24K | n/a | $4.72M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 34.14K | n/a | $3.64M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 6.00K | n/a | $640,380 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 568 holders, 63.82M shares, $11.28B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 2.00K sh · $472,800
Director · 6.00K sh · $1.38M
Officer · 1.20K sh · $289,128
Officer · 2.00K sh · $486,060
Director · 6.00K sh · $1.50M
Officer · 300 sh · $75,828
Officer · 18.11K sh · $4.53M
Officer · 9.26K sh · $2.33M
Officer · 11.42K sh · $2.84M
Officer · 18.19K sh · $4.51M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology